The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 5, 2000, Pages 1429-1436

  Bellomo, Rinaldo ^a   Kellum, John A ^a,b   Gandhi, Chandrashekhar R ^a   Pinsky, Michael R ^a   Ondulik, Brian ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEARANCE; CONTROLLED STUDY; CRITICAL ILLNESS; DOG; ENDOTOXEMIA; FLUID BALANCE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HEMODYNAMIC MONITORING; HEMOFILTRATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SUBSTITUTION THERAPY; ULTRAFILTRATION;

EID: 0034032811     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.5.9809127     Document Type: Article

References (33)

1. 1. Bellomo, R., and C. Ronco. 1998. The changing pattern of severe acute renal failure. Nephrology 2:149-154.
2. 2. Silvester, W., R. Bellomo, and C. Ronco. 1998. Continuous versus intermittent renal replacement therapy in the critically ill. In C. Ronco and R. Bellomo, editors. Critical Care Nephrology, Kluwer Academic Publishers, Dordrecht. 1225-1239.
3. 3. van Bommel, E., N. D. Bouvy, K. L. So, R. Zietse, H. H. Vincent, H. A. Bruning, and W. Weimar. 1995. Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am. J. Nephrol. 15:192-200.
4. 4. Bellomo, R., and C. Ronco. 1996. Acute renal failure in the intensive care unit: adequacy of dialysis and the case for continuous therapies. Nephrol. Dial. Transplant. 11:426-428.
5. 5. Clark, W. R., B. A. Mueller, K. J. Alaka, and W. L. Macias. 1994. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J. Am. Soc. Nephrol. 4:1413-1420.
6. 6. Davenport, A., E. J. Will, and A. M. Davison. 1993. Effect of renal replacement therapy on patients with combined acute renal failure and fulminant hepatic failure. Kidney Int. 41:S245-S251.
7. 7. Sanchez-Izquierdo Riera, J. A., J. L. Perez Vela, M. J. Lozano Quintana, E. Alted Lopez, B. Ortuno de Solo, and A. Ambros Checa. 1997. Cytokine clearance during venovenous hemofiltration in the trauma patient. Am. J. Kidney Dis. 30:483-488.
8. 8. van Bommel, E. F. H. 1997. Should continuous renal replacement therapy be used for "non-renal" indications in critically ill patients with shock? Resuscitation 33:257-270.
9. 9. Bellomo, R., P. Tipping, and N. Boyce. 1993. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit. Care Med. 21:522-526.
10. 10. Lee, P. A., J. R. Matson, R. W. Pryor, and L. B. Hinshaw. 1993. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit. Care Med. 21:914-924.
11. 11. Heering, P., S. Morgera, F. J. Schmitz, G. Schmitz, R. Willers, H. P. Schultheis, B. E. Strauer, B. Grabensee. 1997. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous hemofiltration. Intensive Care Med. 23:288-296.
12. 12. Kellum, J. A., J. P. Johnson, D. Kramer, P. Palevsky, J. J. Brady, and M. R. Pinsky. 1998. Diffusive versus convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit. Care Med. 26:1995-2000.
13. 13. Bellomo, R. 1996. Choosing a therapeutic modality: hemofiltration vs. hemodialysis versus hemodiafiltration. Semin. Dialysis 9:88-92.
14. 14. Grootendorst, A. F., E. F. H. van Bommel, B. van der Hoven, L. A. M. G. van Leengoed, G. A. L. M. van Osta. 1992. High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J. Crit. Care 7:67-75.
15. 15. Gandhi, C. R., L. A. Sproat, and V. M. Subbotin. 1996. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci. 58:55-62.
16. 16. Gandhi, C. R., Y. Kang, A. De Wolf, J. Madariaga, S. Aggarwal, V. Scott, and J. Fung. 1996. Altered endothelin homeostasis in patients undergoing liver transplantation. Liver Transpl. Surg. 2:362-369.
17. 17. Matthews, J. N. S., D. G. Altman, M. J. Campbell, and P. Royston. 1990. Analysis of serial measurements in medical research. B.M.J. 300:230-235.
18. 18. Bellomo, R. 1995. Continuous hemofiltration as blood purification in sepsis. New Horiz. 3:732-737.
19. 19. Gasche, Y., M. Pascual, P. M. Suter, H. Favre, J. C. Chevolet, and J. A. Schifferli. 1996. Complement depletion during hemofiltration with polyacrylonitrile membranes. Nephrol. Dial. Transplant 11:117-119.
20. 20. Tonnessen, E., M. B. Hansen, K. Hohndorf, M. Diamants, K. Bendtzen, M. Wanscher, and P. Toft. 1993. Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth. Intensive Care 21:752-758.
21. 21. Stein, B., E. Pfenninger, A. Grunert, J. E. Schmitz, and M. Hudde. 1990. Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med. 16:494-499.
22. 22. Stein, B., E. Pfenninger, A. Grunert, J. E. Schmitz, A. Deller, and F. Kocher. 1991. The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med. 17:293-298.
23. 23. Mitaka, C., Y. Hirata, K. Makita, T. Nagura, Y. Tsunoda, and K. Amaha. 1993. Endothelin-I and atrial natriuretic peptide in septic shock. Am. Heart J. 126:466-468.
24. 24. Levin, E. R. 1995. Endothelins. N. Engt. J. Med. 333:356-363.
25. 25. Sagiura, M., T. Inagami, and V. Kan. 1989. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. B.B.R.C. 161:1220-1227.
26. 26. Ruetten, H., C. Thiemermann, and J. R. Vane. 1996. Effect of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br. J. Pharmacol. 118:198-204.
27. 27. Weitzberg, E., A. Hemsen, A. Rudehill, A. Modin, M. Wanecek, and J. M. Lundberg. 1996. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxic shock. Br. J. Pharmacol. 118:617-625.
28. 28. Bottoms, G., J. Fessler, E. Murphey, M. Johnson, H. Latshaw, B. Mueller, W. Clark, and W. Macias. 1996. Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 5:149-154.
29. 29. van Bommel, E. F. H., C. J. Hesse, N. H. P. M. Jutte, R. Zietse, H. A. Bruining, and W. Weimar. 1994. Cytokine kinetics (TNF-alpha. IL-1 beta, IL-6) during continuous hemofiltration: a laboratory and clinical study. Contrib. Nephrol. 116:62-75.
30. 30. Szabo, C., J. A. Mitchell, C. Thiemermann, and J. R. Vane. 1993 Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108:786-792.
31. 31. Paya, D., and J. C. Stoelet. 1995. Involvement of bradykinin and nitric oxide in the early hemodynamic effects of lipopolysaccharide in rats. Shock 3:376-379.
32. 32. Schaefer, R. M., E. Fink, L. Shaefer, R. Barkhausen, P. Kulzer, and A. Heidland. 1993. Role of bradykinin in anaphylactoid reactions during hemodialysis with AN 69 dialyzers. Am. J. Nephrol. 13:473-477.
33. 33. Ronco, C., C. Tetta, A. Lupi, E. Galloni, M. C. Bettini, F. Marian, A. De Martino, G. Montrucchio, G. Camussi, and G. La Greca. 1995. Removal of platelet activating factor in experimental continuous arteriovenous hemofiltration. Crit. Care Med. 23:99-107.